<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01381081</url>
  </required_header>
  <id_info>
    <org_study_id>PRP2010</org_study_id>
    <secondary_id>2010-023977-21</secondary_id>
    <nct_id>NCT01381081</nct_id>
  </id_info>
  <brief_title>Platelet-rich Plasma Intra-articular Knee Injections for Knee Osteoarthritis</brief_title>
  <official_title>A Prospective, Randomized, Double-blinded, Clinical Trial, Comparing Platelet-rich Plasma Intra-articular Knee Injections Versus Corticosteroid Intra-articular Knee Injections for Knee Osteoarthritis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital Universitari Vall d'Hebron Research Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital Universitari Vall d'Hebron Research Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The benefit of using platelet rich plasma (PRP) in cartilage injuries, and specifically in
      degenerative ones, has not been assessed yet. Current studies on the PRP healing or repairing
      effect on knee cartilage degenerative injuries are not conclusive to establish a standard of
      behavior, although PRP has shown to improve joint functionality and reduce pain.

      Hypothesis: PRP intra-articular injections in osteoarthritic knees reduces pain and leads to
      a more effective and lasting functional recovering than corticosteroid intra-articular
      injections.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>July 2011</start_date>
  <completion_date type="Actual">January 2014</completion_date>
  <primary_completion_date type="Actual">January 2014</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The value of the visual analogue scale pain (VAS)</measure>
    <time_frame>one month after the treatment</time_frame>
    <description>The difference between the baseline and the value of the scale one month after treatment</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>the value of pain visual analog scale according to</measure>
    <time_frame>4 weeks, 3 and 6 months after treatment</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>the functional level of the knee KOOS</measure>
    <time_frame>4 weeks, 3 and 6 months after treatment</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>All reported adverse events</measure>
    <time_frame>4 weeks, 3 and 6 months after treatment</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Scale of the SF36 quality of life</measure>
    <time_frame>4 weeks, 3 and 6 months after treatment</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">74</enrollment>
  <condition>Knee Osteoarthritis</condition>
  <arm_group>
    <arm_group_label>platelet-rich plasma intra-articular knee injections</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>a single intra-articular injection of PRP in knee osteoarthritis</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Corticosteroid intra-articular knee injections</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>a betamethasone and bupivacaine intra-articular injection</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>platelet-rich plasma</intervention_name>
    <description>a single intra-articular injection</description>
    <arm_group_label>platelet-rich plasma intra-articular knee injections</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Corticosteroid</intervention_name>
    <description>A single betamethasone and bupivacaine intra-articular injection</description>
    <arm_group_label>Corticosteroid intra-articular knee injections</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Degenerative osteoarthritis of the knee confirmed radiologically

          -  Degenerative osteoarthritis of the knee replacement candidate

          -  Walking ability in patients with or without external support

          -  Baseline in pain VAS greater than 60

        Exclusion Criteria:

          -  Neoplastic disease

          -  Immunosuppressive States

          -  Patients who received intra-articular injections of steroids, anesthetic and / or
             hyaluronic acid in the last 3 months.

          -  Patients who have undergone arthroscopic surgery on the last 3 months

          -  Patients with involvement of bone metabolism except osteoporosis (Paget's disease,
             renal osteodystrophy, osteomalacia)

          -  Fibromyalgia or chronic fatigue syndrome

          -  Liver disease

          -  Deficit coagulation (blood dyscrasia)

          -  Thrombocytopenia

          -  Anticoagulant treatment
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nayana Joshi, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Vall d'Hebron</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital Universitario Vall d'Hebron</name>
      <address>
        <city>Barcelona</city>
        <zip>08035</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>February 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 23, 2011</study_first_submitted>
  <study_first_submitted_qc>June 23, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 27, 2011</study_first_posted>
  <last_update_submitted>February 23, 2015</last_update_submitted>
  <last_update_submitted_qc>February 23, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 24, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>knee osteoarthritis</keyword>
  <keyword>comparing platelet-rich plasma</keyword>
  <keyword>intra-articular knee injections</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
    <mesh_term>Osteoarthritis, Knee</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

